Pfizer Tests Transparent Eliquis Pricing As Valuation Signals Undervaluation

Pfizer (NYSE:PFE) and Bristol Myers Squibb are making their blood thinner Eliquis available through the Mark Cuban Cost Plus ...

Pfizer’s PADCEV Keytruda Priority Review Tests Bladder Cancer And Valuation Story

Pfizer (NYSE:PFE) received U.S. FDA Priority Review for a supplemental Biologics License Application covering PADCEV plus ...
Reuters

Astellas-Pfizer's combination therapy halves risk of death in bladder cancer patients

Oct 18 (Reuters) - Pfizer (PFE.N), opens new tab and Japanese firm Astellas' (4503.T), opens new tab drug Padcev, combined with Merck's (MRK.N), opens new tab Keytruda, lowered the risk of tumor ...
Reuters

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

March 17 (Reuters) - Pfizer (PFE.N), opens new tab said on Tuesday its experimental combination reduced the risk of disease progression or death by 40% in patients with breast cancer. Here are some ...
STAT

Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle

Matthew Herper covers medical innovation — both its promise and its perils. An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70%, according to ...
The Motley Fool

Should You Avoid Pfizer? Here's the Key Risk to Watch

Pfizer’s revenue reached $100 billion a few years ago, driven by its dominance in coronavirus treatments and prevention. In recent times, it’s faced a drop in that demand and losses of exclusivity ...
MobiHealthNews

In a study with Pfizer, Akili's neurocognitive assessment video game can detect biomarkers of Alzheimer's

Boston-based Akili Interactive Labs and Pfizer have released data from a collaborative study showing the use of Akili’s digital, cognitive measurement platform can detect biomarkers of Alzheimer’s ...